Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

kopsource ·  {{timeTz}}

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average daily volume of 47,100 shares, the days-to-cover ratio is presently 1.2 days.

BetterLife Pharma Stock Performance

BetterLife Pharma stock opened at $0.11 on Tuesday. BetterLife Pharma has a 52-week low of $0.05 and a 52-week high of $0.30. The firm has a 50 day moving average price of $0.09 and a two-hundred day moving average price of $0.12.

Get BetterLife Pharma alerts:

BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last released its quarterly earnings results on Tuesday, June 28th. The company reported ($0.03) earnings per share (EPS) for the quarter.

BetterLife Pharma Company Profile

(Get Rating)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

Featured Stories

  • Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
  • Green Your Portfolio With These Stocks
  • Bloomin' Brands Is Blossoming
  • Is it Time to Cash Out of Signet Jewelers Stock?
  • MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
  • Deep Value High Yield Newell Brands Is Ready To Bottom

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.

Back to the Top